FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3188411000001109: Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25750101000001110 Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58157801000001110 Seretide 500 Accuhaler (GlaxoSmithKline UK Ltd) 60 dose en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Is a Fluticasone 500micrograms/actuation / Salmeterol 50micrograms/actuation dry powder inhaler 60 dose true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Is pack of Seretide 500 Accuhaler (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has active ingredient Corticosterone false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has active ingredient Salmeterol xinafoate false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has active ingredient Salmeterol false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has active ingredient Fluticasone propionate false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has active ingredient Adrenal hormone agent false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has excipient Lactose false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has manufactured dose form Conventional release powder for inhalation false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has AMP Seretide 500 Accuhaler (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (GlaxoSmithKline) 60 dose Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start